Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| BKNG | BOOKING HOLDINGS INC | $136.16B | 774,878,436 | 4.03% | 1.55% | Net Selling | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $4.22M | 5,208,915 | 3.34% | 96.66% | Net Buying | |||
| VNRX | VOLITIONRX LTD | $11.66M | 8,330,270 | 35.53% | 64.47% | Net Buying | |||
| IMMP | IMMUTEP LTD | $52.46M | 1,473,721,306 | 0.18% | 0.89% | ||||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $22.76M | 32,557,174 | 1.17% | 7.28% | ||||
| HELP | CYBIN INC | $214.05M | 49,894,131 | 48.32% | 0.00% | ||||
| PSTV | PLUS THERAPEUTICS INC | $31.46M | 6,883,106 | 27.31% | 72.69% | Net Buying | |||
| IVVD | INVIVYD INC | $262.79M | 294,607,452 | 71.04% | 28.96% | Net Selling | |||
| ATOS | ATOSSA THERAPEUTICS INC | $19.12M | 8,611,361 | 10.92% | 89.08% | ||||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $94.15M | 123,882,874 | 34.48% | 32.99% | Net Selling | |||
| CNTX | CONTEXT THERAPEUTICS INC | $59.72M | 91,879,177 | 86.17% | 1.43% | ||||
| RNXT | RENOVORX INC | $39.69M | 45,099,133 | 18.99% | 10.05% | Net Buying | Net Buying | ||
| NRXP | NRX PHARMACEUTICALS INC | $143.83M | 36,228,992 | 11.01% | 88.99% | ||||
| TNYA | TENAYA THERAPEUTICS INC | $147.56M | 216,998,876 | 25.03% | 38.16% | Net Selling | Net Selling | ||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $3.88M | 2,659,288 | 6.26% | 93.74% | Net Buying | Net Buying | ||
| OSTX | OS THERAPIES INC | $78.83M | 44,538,106 | 6.51% | 14.34% | ||||
| CTXR | CITIUS PHARMACEUTICALS INC | $14.88M | 27,452,570 | 3.63% | 2.06% | ||||
| BTAI | BIOXCEL THERAPEUTICS INC | $37.05M | 30,877,605 | 2.67% | 97.33% | Net Selling | Net Selling | ||
| KSCP | KNIGHTSCOPE INC | $34.16M | 17,251,663 | 8.19% | 57.52% | ||||
| AVXL | ANAVEX LIFE SCIENCES CORP | $233.53M | 92,671,758 | 42.80% | 4.79% | Net Buying | |||
| CMPX | COMPASS THERAPEUTICS INC | $354.77M | 180,087,915 | 80.75% | 19.25% | Net Buying | Net Buying | ||
| RCT | REDCLOUD HOLDINGS PLC | $38.59M | 59,362,026 | 0.58% | 15.35% | ||||
| OCGN | OCUGEN INC | $399.46M | 338,521,856 | 32.73% | 10.52% | Net Buying | Net Buying | ||
| BMEA | BIOMEA FUSION INC | $83.87M | 72,299,440 | 33.68% | 25.19% | Net Buying | |||
| CRDL | CARDIOL THERAPEUTICS INC | $118.58M | 111,872,084 | 24.82% | 0.00% | ||||
| ELTX | ELICIO THERAPEUTICS INC | $52.68M | 19,086,081 | 13.83% | 59.76% | Net Buying | |||
| VERU | VERU INC | $50.24M | 16,050,320 | 6.64% | 93.36% | ||||
| GUTS | FRACTYL HEALTH INC | $123.11M | 158,648,963 | 45.39% | 18.44% | Net Buying | Net Buying | ||
| LUNG | PULMONX CORP | $52.80M | 42,237,203 | 75.17% | 20.86% | Net Selling | Net Selling | ||
| ALGS | ALIGOS THERAPEUTICS INC | $30.88M | 6,188,223 | 6.77% | 93.23% | ||||
| CRBU | CARIBOU BIOSCIENCES INC | $167.62M | 99,180,575 | 38.16% | 8.68% | Net Selling | |||
| INTZ | INTRUSION INC | $15.52M | 20,369,066 | 7.78% | 74.72% | Net Buying | |||
| NAKA | NAKAMOTO INC | $77.61M | 17,402,140 | 46.16% | 53.84% | Net Buying | Net Buying | ||
| TARA | PROTARA THERAPEUTICS INC | $214.14M | 56,204,237 | 58.75% | 41.25% | Net Selling | Net Selling | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | $396.57M | 266,155,786 | 50.51% | 0.53% | ||||
| HOVR | NEW HORIZON AIRCRAFT LTD | $98.67M | 45,263,348 | 3.75% | 20.15% | Net Selling | |||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $96.27M | 57,301,774 | 65.60% | 34.40% | Net Buying | Net Buying | ||
| MDXH | MDXHEALTH SA | $2.76M | 51,364,520 | 40.85% | 59.15% | ||||
| MNOV | MEDICINOVA INC | $64.48M | 49,221,246 | 10.98% | 88.78% | ||||
| ACET | ADICET BIO INC | $72.54M | 9,348,236 | 28.27% | 71.73% | Net Buying | Net Selling | ||
| CAN | CANAAN INC | $239.45M | 10,358,912,865 | 1.40% | 3.58% | ||||
| CING | CINGULATE INC | $62.93M | 13,276,022 | 8.95% | 32.96% | Net Buying | |||
| ENGN | ENGENE THERAPEUTICS INC | $117.23M | 66,989,466 | 74.71% | 25.29% | ||||
| NSRX | NASUS PHARMA LTD | $27.68M | 9,015,383 | 24.12% | 58.94% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.